RT Journal Article
SR Electronic
T1 <strong><em>Waf-1</em></strong> (<strong><em>p21</em></strong>) and <strong><em>p53</em></strong> Polymorphisms in Breast Cancer
JF Cancer Epidemiology Biomarkers &amp; Prevention
JO Cancer Epidemiol Biomarkers Prev
FD American Association for Cancer Research
SP 127
OP 130
VO 11
IS 1
A1 Keshava, Channa
A1 Frye, Bonnie L.
A1 Wolff, Mary S.
A1 McCanlies, Erin C.
A1 Weston, Ainsley
YR 2002
UL http://cebp.aacrjournals.org/content/11/1/127.abstract
AB p53 is a transcription factor for Waf-1/p21, a cyclin-dependent kinase inhibitor. Certain polymorphic variants of Waf-1 and p53 have been evaluated for their association with cancer risk. Previous studies indicated that certain p53 polymorphisms confer an increased risk of breast cancer [odds ratios (ORs) and 95% confidence intervals (CIs) = 2.9, 1.4–6.3 Carcinogenesis (Lond.), 17: 1313, 1996; 2.5, 1.3–4.8 Cancer Epidemiol. Biomark. Prev., 6: 105, 1997; and 1.5, 1.1–2.0, Anticancer Res., 18: 2095, 1998). The primary objectives of this study were to test the hypotheses that the serine variant (codon 31 polymorphism) of Waf-1 is also involved in this process and that there is an interaction between Waf-1 and p53 polymorphisms. To do this, Waf-1 and p53 genotypes were determined for women enrolled in a breast cancer case-control study (Caucasians, African-Americans and Latinas; 487 Waf-1 and 504 p53 genotypes were obtained). Multivariate logistic regression was used to evaluate possible associations between Waf-1 and p53 polymorphisms, race, and menopause. The primary aim was to determine whether an interaction between Waf-1 and p531–2-1 existed. Whereas multivariate analysis suggested associations between breast cancer and inheritance of Waf-1ser31 in African-Americans (OR, 2.32; 95% CI = 0.66–5.60; n = 37 cases and 65 controls) and Latinas (OR, 2.22; 95% CI = 0.71–6.89; n = 30 cases and 75 controls), and inheritance of p531–2-1 in Caucasians (OR, 3.15; 95% CI = 1.14–8.89; n = 93 cases and 187 controls), we did not see an interaction between Waf-1ser31 and p531–2-1. Consistent with the finding that p531–2-1 is a risk factor for Caucasian women was the observation of a strong interaction between race and p53 (P &lt; 0.01).